Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2007
03/08/2007CA2604551A1 Jak kinase inhibitors and their uses
03/08/2007CA2602442A1 Ep2 receptor agonists for treating glaucoma
03/08/2007CA2540459A1 Benzimidazole compounds and uses in treating proliferative disorders
03/07/2007EP1760083A1 Rapamycin hydroxyesters, process for their preparation and pharmaceutical compositions containing them
03/07/2007EP1760082A1 N-(4-(4-methylthiazol-5-yl) pyrimidin-2-yl)-N-phenylamines as anti-proliferative compounds
03/07/2007EP1760079A1 Compounds as cor5 antagonists
03/07/2007EP1760076A1 FAP Inhibitors
03/07/2007EP1760073A1 Sulfonamide compound
03/07/2007EP1760071A1 Compound having s1p receptor binding potency and use thereof
03/07/2007EP1759734A2 Aromatase inhibition to enhance assisted reproduction
03/07/2007EP1759703A1 Immunistimulative and interferonogenous agent
03/07/2007EP1759702A1 Method of preparing a latanoprost ophthalmic solution and solution thus produced
03/07/2007EP1759701A2 Buproprion Metabolites and Methods of Their Synthesis and Use.
03/07/2007EP1759700A1 Use of a PDE5 inhibitor for treating and preventing hypopigmentary disorders
03/07/2007EP1759699A1 Liposome preparation containing slightly water-soluble camptothecin
03/07/2007EP1759698A1 Novel method of treatment
03/07/2007EP1759696A1 Antineoplastic cocoa extracts, methods for making, using
03/07/2007EP1759695A1 Lactate containing pharmaceutical composition and uses thereof
03/07/2007EP1759694A2 Combinations of DMXAA and other anti-cancer agents
03/07/2007EP1759693A2 Percutaneous absorption-type pharmaceutical preparations
03/07/2007EP1759691A1 Stable liposome compositions
03/07/2007EP1758998A2 Oligoribonucleotides and methods of use thereof for treatment of fibrotic conditions and other diseases
03/07/2007EP1758990A2 Method for ameliorating an inflammatory skin condition
03/07/2007EP1758921A2 Compounds for proteasome enzyme inhibition
03/07/2007EP1758919A1 Estrogen receptor modulators
03/07/2007EP1758916A1 3-BETA-D-RIBOFURANOSYLTHIAZOLO[4,5-d]PYRIDIMINE NUCLEOSIDES AND USES THEREOF
03/07/2007EP1758915A2 Composition and method for inhibiting platelet aggregation
03/07/2007EP1758914A1 Novel fluoroglycoside derivatives of pyrazoles, medicaments containing these compounds, and the use thereof
03/07/2007EP1758911A1 1-heterocyclyl-1,5-dihydro-pyrido[3,2-b]indol-2-ones
03/07/2007EP1758910A1 Substituted triazole derivatives as oxytocin antagonists
03/07/2007EP1758909A1 Furanopyrimidine compounds effective as potassium channel inhibitors
03/07/2007EP1758907A1 Diphenylimidazopyrimidine and -imidazole amines as inhibitors of b-secretase
03/07/2007EP1758905A1 8-[3-amino-piperidin-1-yl]-xanthine, the production thereof and the use in the form of a ddp-iv inhibitor
03/07/2007EP1758904A1 Flavopereirine derivatives for cancer therapy
03/07/2007EP1758903A1 Pyrrolopyramidine and pyrrolopyridine derivatives substituted with a cyclic amino group as crf antagonists
03/07/2007EP1758902A1 Amino-halogen-imidazopyridines as proton pump inhibitors
03/07/2007EP1758900A1 Substituted tricyclic benzimidazoles
03/07/2007EP1758898A1 Indolylalkylamine metabolites as 5-hydroxytrytamine-6 ligands
03/07/2007EP1758897A1 Novel diazine derivatives, their manufacture and use as pharmaceutical agents
03/07/2007EP1758895A1 Gonadotropin releasing hormone receptor antagonists
03/07/2007EP1758893A1 Substituted diketopiperazines as oxytocin antagonists
03/07/2007EP1758892A1 Compounds and compositions as protein kinase inhibitors
03/07/2007EP1758891A2 Benzimidazolone carboxylic acid derivatives
03/07/2007EP1758890A1 7-pyrazolylbenzazepines having affinity for d3 receptor
03/07/2007EP1758888A1 Butyrylcholinesterase selective inhibitors
03/07/2007EP1758887A1 Pyrimidine derivatives for the treatment of abnormal cell growth
03/07/2007EP1758886A1 Piperazinediones as oxytocin receptor antagonists
03/07/2007EP1758884A2 N-cyclic sulfonamido inhibitors of gamma secretase
03/07/2007EP1758883A1 Substituted 2-quinolyl-oxazoles useful as pde4 inhibitors
03/07/2007EP1758882A1 Amido compounds and their use as pharmaceuticals
03/07/2007EP1758881A1 Thiophene hydroxamic acid derivatives and their use as hdac inhibitors
03/07/2007EP1758880A1 Hydroxamates, their manufacture and use as pharmaceutical agents
03/07/2007EP1758879A1 Method of manufacturing (s)-n-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propylamine hydrochloride (duloxetine)
03/07/2007EP1758874A1 Substituted thiazoleacetic acids as crth2 ligands
03/07/2007EP1758873A1 Ubiquitin ligase inhibitors
03/07/2007EP1758872A1 Process for the preparation of anastrozole
03/07/2007EP1758871A1 Pyrazolo pyrimidines
03/07/2007EP1758870A1 4-phenyl-pyrimidine-2-carbonitrile derivatives
03/07/2007EP1758869A1 Pyridazin-3(2h)-one derivatives and their use as pde4 inhibitors
03/07/2007EP1758868A1 Novel cis-imidazolines
03/07/2007EP1758866A1 Processes for preparing 6-alkyl-5-arylsulfonyl- dihydrophenanthridines
03/07/2007EP1758865A1 Pyridine analogs as c5a antagonists
03/07/2007EP1758864A1 Substituted tetrahydro-2h-isoquinolin-1-one derivatives, method for the production thereof, and use of the same as medicaments
03/07/2007EP1758863A1 Tetrahydroquinolones and aza-analogues thereof for use as dpp-iv inhibitors in the treatement of diabetes
03/07/2007EP1758862A1 Aminopyridine derivatives as selective dopamine d3 agonists
03/07/2007EP1758861A1 Dpp-iv inhibitors
03/07/2007EP1758860A1 Saturated and unsaturated 3-pyridyl-benzocycloalkylmethyl-amines for use in the treatment of pains, depressions and anxiety states
03/07/2007EP1758859A1 Glucagon receptor antagonists, preparation and therapeutic uses
03/07/2007EP1758857A1 Indole derivatives as antiviral agents
03/07/2007EP1758856A2 Indole derivatives for the treatment of obesity
03/07/2007EP1758854A1 Pyrrolidin-3-yl compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease
03/07/2007EP1758853A1 Glucagon receptor antagonists, preparation and therapeutic uses
03/07/2007EP1758852A2 Substituted cyclopentene compounds
03/07/2007EP1758851A1 Vanilloid trpv1 receptor antagonists
03/07/2007EP1758847A1 Inhibitors of histone deacetylase
03/07/2007EP1758655A2 Tetrahydropyridothiophenes for treating hyperproliferative disorders
03/07/2007EP1758654A1 Use of c-kit inhibitors for treating plasmodium related diseases
03/07/2007EP1758653A2 Treatments comprising strontium for rheumatic and arthritic diseases and pain
03/07/2007EP1758652A2 Improving pain treatment with strontium combinations
03/07/2007EP1758651A2 Lxr agonists to promote bone homeostasis
03/07/2007EP1758640A2 Inhibition of hiv-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein
03/07/2007EP1758621A1 Bioactive biomaterials for controlled delivery of active principles
03/07/2007EP1758613A2 Compositions and methods for modulating bone mass
03/07/2007EP1758611A2 Use of liver-selective glucokinase activators
03/07/2007EP1758606A1 Novel use of peptide compounds for treating essential tremor and other tremor syndromes
03/07/2007EP1758603A1 Treatment for asthma and arthritis and other inflammatory diseases
03/07/2007EP1758601A1 Treatment with cisplatin and an egfr-inhibitor
03/07/2007EP1758600A1 Methods and compositions for treating mood disorder
03/07/2007EP1758597A1 Use of drug combinations for treating insulin resistance
03/07/2007EP1758596A2 Purine derivatives as adenosine a1 receptor agonists and methods of use thereof
03/07/2007EP1758595A2 Use of lipid conjugates in the treatment of diseases
03/07/2007EP1758594A1 Combination for inhibiting bone resorption comprising a bisphosponate (alendrona) and a vitamin d (cholecalciferol)
03/07/2007EP1758593A1 Vascular damaging agents for administration as an intravenous infusion
03/07/2007EP1758592A1 Treatment of cancer in pediatric patients
03/07/2007EP1758591A1 Invert emulsion composition containing calcitriol and clobetasol 17-propionate, and uses thereof in cosmetics and dermatology
03/07/2007EP1758590A1 Use of a detergent for the non-surgical removal of fat
03/07/2007EP1758589A1 Composition for the treatment of psoriasis comprising a silicone agent, a corticosteroid and vitamin d or a derivative thereof
03/07/2007EP1758588A1 Pharmaceutical composition comprising an ointment and two solubilized active principles
03/07/2007EP1758587A1 Use of a pharmaceutical composition comprising calcitriol and clobetasol propionate for the treatment of psoriasis
03/07/2007EP1758586A1 Composition in spray form comprising a combination of a corticoid and a vitamin d derivative in an oily phase
1 ... 3849 3850 3851 3852 3853 3854 3855 3856 3857 3858 3859 3860 3861 3862 3863 3864 3865 3866 3867 3868 3869 ... 7860